Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells
Developmental Cell · 2025
DOI: 10.1016/j.devcel.2025.04.005 ↗At a glance
Journal article in Developmental Cell, 2025. Written by Zhijie Li and 14 co-authors. Institution: Department of Surgery, University of Iowa, Iowa City, IA 52242, USA. Major MEDLINE topics: Neoplastic Stem Cells, Carcinogenesis, Transcription Factors, DNA-Binding Proteins. Cited 8 times so far (Crossref); 80 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, University of Iowa, National Institutes of Health National Cancer Institute.
Abstract (original language)
The small ubiquitin-like modifier (SUMO) pathway is required for maintenance of cancer stem cells/tumor-initiating cells (CSCs/TICs), which drive tumorigenesis when transplanted into immunocompromised mice. We found that inhibition of the SUMO pathway blocked Neu-mediated mammary oncogenesis and inhibited the function of CSCs/TICs without effects on normal mammary stem cells. Transcriptomic analysis implicated SUMO-conjugated Etv1 as being critical for oncogenesis. After SUMO pathway inhibition, a SUMO-mimetic Etv1 protein, created by a fusion with SUMO1 or SUMO2, established a stem-like cell capable of tumorigenesis, whereas a SUMO-resistant Etv1 protein established a proliferative, non-tumorigenic cell. In mixing experiments, stem-like cells induced tumorigenesis by non-stem cells. We conclude that SUMO-conjugated Etv1 is necessary to maintain the CSC/TIC phenotype and that crosstalk between stem and non-stem cells is crucial for tumorigenesis. The findings demonstrate dynamic interactions between heterogeneous cell types to drive tumorigenesis, which has implications for future cancer therapeutic development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, University of Iowa, Iowa City, IA 52242, USA.
- Department of Pathology, University of Iowa, Iowa City, IA 52242, USA.
- Department of Surgery, University of Iowa, Iowa City, IA 52242, USA. Electronic address: ronald-weigel@uiowa.edu.
Funding
- NCI NIH HHS
- University of Iowa
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- Society of University Surgeons
- US Department of Defense
Cite
APA
Li, Z., Koch, K. E., Thompson, D. T., Van der Heide, D. M., Chang, J., Franke, C. M., Suraju, M. O., Beck, A. C., Lorenzen, A. W., White, J. R., Bartschat, N. I., Kulak, M. V., Meyerholz, D. K., Kenny, C., & Weigel, R. J. (2025). Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells. Developmental Cell. https://doi.org/10.1016/j.devcel.2025.04.005
Vancouver
Li Z, Koch KE, Thompson DT, Van der Heide DM, Chang J, Franke CM, et al. Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells. Developmental Cell. 2025. doi:10.1016/j.devcel.2025.04.005
BibTeX
@article{Li2025,
author = {Li, Zhijie and Koch, Kelsey E and Thompson, Dakota T and Van der Heide, Dana M and Chang, Jeremy and Franke, Christopher M and Suraju, Mohammed O and Beck, Anna C and Lorenzen, Allison W and White, Jeffrey R and Bartschat, Nicholas I and Kulak, Mikhail V and Meyerholz, David K and Kenny, Colin and Weigel, Ronald J},
title = {Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells},
journal = {Developmental Cell},
year = {2025},
doi = {10.1016/j.devcel.2025.04.005}
}
EUVIMED